Sequencing of systemic treatment for hepatocellular carcinoma: Second line competitors
Author:
Publisher
Baishideng Publishing Group Inc.
Subject
Gastroenterology,General Medicine
Reference55 articles.
1. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level
2. Insights into the success and failure of systemic therapy for hepatocellular carcinoma
3. Sorafenib in Advanced Hepatocellular Carcinoma
4. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
5. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Innovative Nickel Oxide-Pluronic F127-Escin Hybrids: Synthesis, Characterization, and Dual Bioactivity Against Bacteria and Cancer Cells;Journal of Inorganic and Organometallic Polymers and Materials;2024-08-31
2. Atezolizumab and Bevacizumab Combination Therapy in the Treatment of Advanced Hepatocellular Cancer;Cancers;2023-12-30
3. From evidence to clinical practice: Bridging the gap of new liver cancer therapies in Latin America.;Annals of Hepatology;2023-12
4. HSP90, as a functional target antigen of a mAb 11C9, promotes stemness and tumor progression in hepatocellular carcinoma;Stem Cell Research & Therapy;2023-09-27
5. The New Era of Systemic Treatment for Hepatocellular Carcinoma: From the First Line to the Optimal Sequence;Current Oncology;2023-09-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3